| Monday, January 10, 2011 |
| 07:30:00 |
Conference Registration and Morning Coffee |
|
| 08:25:00 |
Introductory Perspectives: Particulates And Product Quality |
|
| 08:30:00 |
Chairperson’s Opening Remarks |
|
| 08:45:00 |
Recent Perspectives on Aggregates and Particulates in Biologics Formulations |
Palani Palaniappan
|
| 09:35:00 |
The Formulation and Immunogenicity of Therapeutic Proteins: Product Quality as a Key Factor |
Joel Richard
|
| 10:05:00 |
Coffee Break Featuring Emerging Companies/Products |
|
| 10:40:00 |
Formulation Screening And Optimization |
|
| 10:45:00 |
Screening for Protein Stability |
Matthías Thórólfsson
|
| 11:15:00 |
Increasing Efficiency of Formulation Development for Adnectins through High- Throughput Screening |
Bernice Yeung
|
| 11:45:00 |
A High-Throughput Method to Predict the Aggregation Propensity of Proteins |
Neeraj J Agrawal
|
| 12:15:00 |
Close of Morning Session |
|
| 12:30:00 |
Luncheon Presentations | Lunch on Your Own |
|
| 13:55:00 |
Formulation Screening And OptimizatioN | (Continued) |
|
| 14:00:00 |
Chairperson’s Remarks |
|
| 14:05:00 |
The Use of Forced Degradation to Optimize Protein Formulation |
J. Andrea Ji
|
| 14:25:00 |
Predictive Tools For Formulation Development |
|
| 14:35:00 |
Early Formulation Screening of Monoclonal Antibodies: Selecting Molecules with Optimal Physical and Chemical Stability |
Vikas Sharma
|
| 15:05:00 |
Rational Choice of Excipients for Lyophilized Formulations |
Evgenyi Shalaev
|
| 15:35:00 |
Sponsored Presentation |
|
| 15:50:00 |
Refreshment Break Featuring Emerging Companies/Products |
|
| 16:30:00 |
Hydrogen/Deuterium Exchange with Mass Spectrometric Analysis for Assessing Conformation and Excipient Interactions of Lyophilized Proteins |
Elizabeth Topp
|
| 17:00:00 |
Sponsored Presentation |
|
| 17:30:00 |
Causal Factors and Correlations in Freeze-Dried Protein Stability |
Marcus Cicerone
|
| 18:00:00 |
Welcoming Reception | Exhibit Hall |
|
| 19:30:00 |
Close of Day |
|
| Tuesday, January 11, 2011 |
| 07:30:00 |
Breakfast Presentation | Morning Coffee |
|
| 08:10:00 |
PART ICLE ANALYSIS |
|
| 08:15:00 |
Chairperson’s Opening Remarks |
|
| 08:20:00 |
Particle Analysis as a Formulation Development Tool |
Shannon Southall
|
| 08:50:00 |
Particles and Aggregates in Biotech Drug Products |
Hanns-Christian Mahler
|
| 09:15:00 |
CASE STUDIES |
|
| 09:20:00 |
Formulation Development of Dual-Variable-Domain Immunoglobulins as the Next- Generation of Bispecific Biologics |
Wolfgang Fraunhofer
|
| 09:50:00 |
Automated Measurement of Protein Conformation in Solution Using the ChirascanTM-auto |
David Gregson
|
| 10:05:00 |
Coffee Break | Exhibit and Poster Viewing |
|
| 10:45:00 |
An Alternative Approach for Delivering High Dose Biologics Subcutaneously |
Tzung Yang
|
| 11:15:00 |
Early Development of a Novel Formulation for Inhalation |
Andrea Leone-Bay Leone-Bay
|
| 11:45:00 |
Optimizing Processing Conditions to Avoid Process Stress Induced Aggregation |
Carl Charlie Hitscherich
|
| 12:15:00 |
Close of Morning Session |
|
| 12:30:00 |
Luncheon Presentations |
|
| 14:00:00 |
BuzZ Session A | Interactive participation leads to problem-solving solutions and future collaborations around focused topics |
|
| 14:45:00 |
Refreshment Break | Exhibit Viewing and Poster Awards |
|
| 15:30:00 |
BuzZ Session B | Interactive participation leads to problem-solving solutions and future collaborations around focused topics |
|
| 16:15:00 |
End of Conference |
|
| 16:30:00 |
Concurrent Dinner Short Courses |
|
How We Rank